AI drug discovery startup Converge Bio raised $25 million in a Series A led by Bessemer Venture Partners, with additional ...

Understanding human gene function in living organisms has long been hampered by fundamental differences between species.

AI-generated deception is best detected not by examining isolated data points, but by analyzing how content behaves over time ...

Tabular foundation models are the next major unlock for AI adoption, especially in industries sitting on massive databases of ...

A dichotomy is forming between the personal and the professional when it comes to AI adoption. While generative AI and ...

Google Gemini may perform competency very convincingly, but if you use it for everything, you may end up dealing with wrong ...

Last week at CES, Lego introduced its new Smart Play system, with a tech-packed Smart Brick that can recognize and interact ...

A context-driven memory model simulates a wide range of characteristics of waking and sleeping hippocampal replay, providing a new account of how and why replay occurs.

Accelerated drug discovery and development platform Converge Bio Inc. today announced it has raised $25 million in ...

Converge Bio, the AI platform for accelerated drug discovery and development, announced today $25 million in Series A funding ...

Furthermore, Nano Banana Pro still edged out GLM-Image in terms of pure aesthetics — using the OneIG benchmark, Nano Banana 2 ...

Traffic is down, but publisher content still drives sales. Partnerize's attribution model lets publishers measure performance ...